the present correlative data, in conjunction with our data, indicate that co-expression of the EPHB2 receptor and EFNB1 ligand is significantly associated with high metastatic potential and poor prognosis of GC. Mechanistically, signal downstream of the EPHB2 receptor, activated by the EFNB1 ligand, mediates the modulation of adhesion molecules and tight junctions in GC cells through the Wnt/β-catenin/WISP-1/FAK signaling axis, promoting metastasis in GC (Fig. 7E).